首页 > 最新文献

Anaesthesia Critical Care & Pain Medicine最新文献

英文 中文
Efficacy of ultrasound guided sphenopalatine ganglion block in management of emergence agitation after sinoscopic nasal surgery: a randomized double-blind controlled study 超声引导下的鼻骨神经节阻滞治疗鼻窦镜手术后出现躁动的疗效:一项随机双盲对照研究。
IF 3.7 3区 医学 Q1 ANESTHESIOLOGY Pub Date : 2024-10-02 DOI: 10.1016/j.accpm.2024.101429
Rasha Hamed , Loay Gamal , Saeid Elsawy , Mohammed Abdelmoneim Baker , Yara Hamdy Abbas

Background

Nasal surgery has a reported high incidence of agitation during emergence from general anesthesia. Emergence Agitation (EA) increases the risk of surgical site bleeding, falling off the operating table, removal of catheters and intravenous lines, and self-extubation. This study investigated the role of nerve block in EA.

Objectives

This study evaluated the effect of ultrasound-guided sphenopalatine ganglion block (SPGB) on EA after sinoscopic nasal surgery. The primary outcome was the incidence of EA. Secondary outcomes included the quality of the surgical field, bleeding volume, inhalational anesthesia, MAC, VAS in the PACU, postoperative analgesia duration, and total 24 -h opioid consumption.

Patients and methods

This double-blind, randomized controlled study enrolled 120 patients, of whom 110 completed the study. They were randomly allocated into two equal groups: G1, which received general anesthesia and a bilateral sphenopalatine ganglion block (SPBG) with 5 mL lidocaine 2% on each side, and G2 (control), which received general anesthesia and a bilateral sphenopalatine saline injection of 5 mL on each side.

Results

A significant decrease in the incidence of EA was found in G1 compared to G2 (20% vs. 64%). Intraoperative bleeding volume was significantly lower, and surgical field quality was significantly higher in G1 compared to G2. Pain severity was significantly lower in G1 in the PACU, and 24 h postoperative opioid consumption was significantly reduced compared to G2. Additionally, postoperative analgesia duration was significantly longer in G1 than in G2 (9 h vs. 3 h).

Conclusion

SPGB effectively reduced EA incidence, severity, and duration after sinoscopic nasal surgery. Furthermore, SPGB reduced intraoperative bleeding, improved surgical field quality, prolonged postoperative analgesia, and reduced 24 -h opioid consumption after sinoscopic nasal surgery.

Registration

National Clinical Trial Registry, NCT04168879.
背景:据报道,鼻腔手术在全身麻醉后出现躁动的发生率很高。出院躁动(EA)会增加手术部位出血、跌落手术台、拔除导管和静脉管路以及自行拔管的风险。本研究调查了神经阻滞在 EA 中的作用:本研究评估了超声引导下的脊神经节阻滞(SPGB)对鼻窦镜手术后 EA 的影响。主要结果是 EA 的发生率。次要结果包括手术野的质量、出血量、吸入麻醉、MAC、PACU 的 VAS、术后镇痛持续时间和 24 小时阿片类药物总消耗量:这项双盲随机对照研究共招募了 120 名患者,其中 110 人完成了研究。他们被随机分配到两个相同的组别:G1组接受全身麻醉和双侧椎旁神经节阻滞(SPBG),每侧5毫升2%利多卡因;G2组(对照组)接受全身麻醉和双侧椎旁生理盐水注射,每侧5毫升:结果:与 G2 相比,G1 的 EA 发生率明显降低(20% 对 64%)。与 G2 相比,G1 的术中出血量明显减少,手术视野质量明显提高。与 G2 相比,G1 在 PACU 中的疼痛严重程度明显降低,术后 24 小时的阿片类药物用量也明显减少。此外,G1 的术后镇痛时间明显长于 G2(9 小时对 3 小时):SPGB有效降低了鼻窦镜手术后EA的发生率、严重程度和持续时间。此外,SPGB 减少了鼻窦手术后的术中出血,改善了手术视野质量,延长了术后镇痛时间,减少了 24 小时阿片类药物的用量:注册:国家临床试验注册中心,NCT04168879。
{"title":"Efficacy of ultrasound guided sphenopalatine ganglion block in management of emergence agitation after sinoscopic nasal surgery: a randomized double-blind controlled study","authors":"Rasha Hamed ,&nbsp;Loay Gamal ,&nbsp;Saeid Elsawy ,&nbsp;Mohammed Abdelmoneim Baker ,&nbsp;Yara Hamdy Abbas","doi":"10.1016/j.accpm.2024.101429","DOIUrl":"10.1016/j.accpm.2024.101429","url":null,"abstract":"<div><h3>Background</h3><div>Nasal surgery has a reported high incidence of agitation during emergence from general anesthesia. Emergence Agitation (EA) increases the risk of surgical site bleeding, falling off the operating table, removal of catheters and intravenous lines, and self-extubation. This study investigated the role of nerve block in EA.</div></div><div><h3>Objectives</h3><div>This study evaluated the effect of ultrasound-guided sphenopalatine ganglion block (SPGB) on EA after sinoscopic nasal surgery. The primary outcome was the incidence of EA. Secondary outcomes included the quality of the surgical field, bleeding volume, inhalational anesthesia, MAC, VAS in the PACU, postoperative analgesia duration, and total 24 -h opioid consumption.</div></div><div><h3>Patients and methods</h3><div>This double-blind, randomized controlled study enrolled 120 patients, of whom 110 completed the study. They were randomly allocated into two equal groups: G1, which received general anesthesia and a bilateral sphenopalatine ganglion block (SPBG) with 5 mL lidocaine 2% on each side, and G2 (control), which received general anesthesia and a bilateral sphenopalatine saline injection of 5 mL on each side.</div></div><div><h3>Results</h3><div>A significant decrease in the incidence of EA was found in G1 compared to G2 (20% <em>vs</em>. 64%). Intraoperative bleeding volume was significantly lower, and surgical field quality was significantly higher in G1 compared to G2. Pain severity was significantly lower in G1 in the PACU, and 24 h postoperative opioid consumption was significantly reduced compared to G2. Additionally, postoperative analgesia duration was significantly longer in G1 than in G2 (9 h <em>vs</em>. 3 h).</div></div><div><h3>Conclusion</h3><div>SPGB effectively reduced EA incidence, severity, and duration after sinoscopic nasal surgery. Furthermore, SPGB reduced intraoperative bleeding, improved surgical field quality, prolonged postoperative analgesia, and reduced 24 -h opioid consumption after sinoscopic nasal surgery.</div></div><div><h3>Registration</h3><div>National Clinical Trial Registry, NCT04168879.</div></div>","PeriodicalId":48762,"journal":{"name":"Anaesthesia Critical Care & Pain Medicine","volume":"43 6","pages":"Article 101429"},"PeriodicalIF":3.7,"publicationDate":"2024-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142376183","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of perioperative erythropoietin on postoperative morbidity and mortality after cardiac surgery: a meta-analysis of randomized controlled trials 围手术期促红细胞生成素对心脏手术术后发病率和死亡率的影响:随机对照试验荟萃分析。
IF 3.7 3区 医学 Q1 ANESTHESIOLOGY Pub Date : 2024-10-02 DOI: 10.1016/j.accpm.2024.101428
Dana Abraham , Dror B. Leviner , Tom Ronai , Naama Schwartz , Amos Levi , Erez Sharoni

Objective

Cardiac surgery is known to have high rates of perioperative red blood cell (RBC) transfusions which are associated with increased postoperative mortality and morbidity. Perioperative erythropoietin (EPO) has been suggested to lower perioperative RBC transfusions, and the effect on postoperative morbidity or mortality is unknown.

Methods

The registered study protocol is available on PROSPERO (CRD42022314538). We searched the Pubmed, EMbase, and Cochrane CENTRAL databases for randomized controlled trials (RCT) of EPO in cardiac surgery. Outcomes were short-term mortality, acute kidney injury (AKI), re-operation, cerebrovascular accident (CVA), perioperative myocardial infarction (MI), infectious complications, and RBC transfusions. RCT studies of perioperative EPO that reported at least one prespecified outcome of interest were included.

Results

A total of 21 RCT’s (n = 2,763 patients) were included. Mortality analysis included 17 studies (EPO 1,272 patients, control 1,235) and showed no significant difference (risk difference (RD) 0.0004, 95%CI: −0.016, 0.009). EPO did not reduce the incidence of AKI (RD −0.006, 95% CI: −0.038, 0.026) and reoperation (RD 0.001, 95% CI: −0.013, 0.015). The incidence of CVA (RD −0.004, 95% CI: −0.015, 0.007) and perioperative MI (RD −0.008, 95% CI: −0.021, 0.005) was similar between the groups.

Conclusions

Although EPO had been proven to reduce perioperative RBC transfusions, we did not find that it reduces the incidence of postoperative short-term mortality, AKI, and reoperation. The study results support that perioperative EPO is also safe, with no rise in thrombotic events, including CVA and perioperative MI.
目的:众所周知,心脏手术的围手术期红细胞(RBC)输注率很高,这与术后死亡率和发病率的增加有关。围手术期促红细胞生成素(EPO)被认为可降低围手术期红细胞输注率,但其对术后发病率或死亡率的影响尚不清楚:已登记的研究方案可在 PROSPERO (CRD42022314538) 上查阅。我们在 Pubmed、EMbase 和 Cochrane CENTRAL 数据库中检索了心脏手术中 EPO 的随机对照试验 (RCT)。研究结果包括短期死亡率、急性肾损伤(AKI)、再次手术、脑血管意外(CVA)、围手术期心肌梗死(MI)、感染性并发症和红细胞输注。结果:共纳入了 21 项关于围手术期 EPO 的研究:结果:共纳入 21 项 RCT 研究(n = 2,763 名患者)。死亡率分析包括 17 项研究(EPO 1,272 例患者,对照组 1,235 例),结果显示两者无显著差异(风险差异 (RD) 0.0004,95%CI:-0.016, 0.009)。EPO 并未降低 AKI(RD -0.006,95% CI:-0.038,0.026)和再次手术(RD 0.001,95% CI:-0.013,0.015)的发生率。两组间CVA(RD -0.004,95% CI:-0.015,0.007)和围手术期心肌梗死(RD -0.008,95% CI:-0.021,0.005)的发生率相似:结论:尽管 EPO 已被证实可减少围手术期红细胞输注,但我们并未发现它能降低术后短期死亡率、AKI 和再次手术的发生率。研究结果表明,围手术期使用 EPO 也是安全的,血栓事件(包括 CVA 和围手术期心肌梗死)不会增加。
{"title":"Effect of perioperative erythropoietin on postoperative morbidity and mortality after cardiac surgery: a meta-analysis of randomized controlled trials","authors":"Dana Abraham ,&nbsp;Dror B. Leviner ,&nbsp;Tom Ronai ,&nbsp;Naama Schwartz ,&nbsp;Amos Levi ,&nbsp;Erez Sharoni","doi":"10.1016/j.accpm.2024.101428","DOIUrl":"10.1016/j.accpm.2024.101428","url":null,"abstract":"<div><h3>Objective</h3><div>Cardiac surgery is known to have high rates of perioperative red blood cell (RBC) transfusions which are associated with increased postoperative mortality and morbidity. Perioperative erythropoietin (EPO) has been suggested to lower perioperative RBC transfusions, and the effect on postoperative morbidity or mortality is unknown.</div></div><div><h3>Methods</h3><div>The registered study protocol is available on PROSPERO (CRD42022314538). We searched the Pubmed, EMbase, and Cochrane CENTRAL databases for randomized controlled trials (RCT) of EPO in cardiac surgery. Outcomes were short-term mortality, acute kidney injury (AKI), re-operation, cerebrovascular accident (CVA), perioperative myocardial infarction (MI), infectious complications, and RBC transfusions. RCT studies of perioperative EPO that reported at least one prespecified outcome of interest were included.</div></div><div><h3>Results</h3><div>A total of 21 RCT’s (n = 2,763 patients) were included. Mortality analysis included 17 studies (EPO 1,272 patients, control 1,235) and showed no significant difference (risk difference (RD) 0.0004, 95%CI: −0.016, 0.009). EPO did not reduce the incidence of AKI (RD −0.006, 95% CI: −0.038, 0.026) and reoperation (RD 0.001, 95% CI: −0.013, 0.015). The incidence of CVA (RD −0.004, 95% CI: −0.015, 0.007) and perioperative MI (RD −0.008, 95% CI: −0.021, 0.005) was similar between the groups.</div></div><div><h3>Conclusions</h3><div>Although EPO had been proven to reduce perioperative RBC transfusions, we did not find that it reduces the incidence of postoperative short-term mortality, AKI, and reoperation. The study results support that perioperative EPO is also safe, with no rise in thrombotic events, including CVA and perioperative MI.</div></div>","PeriodicalId":48762,"journal":{"name":"Anaesthesia Critical Care & Pain Medicine","volume":"43 6","pages":"Article 101428"},"PeriodicalIF":3.7,"publicationDate":"2024-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142376182","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Propofol does not alter the protein binding and unbound concentration of lidocaine at clinically targeted plasma concentrations in vitro – A short communication 丙泊酚在体外不会改变利多卡因在临床目标血浆浓度下的蛋白结合和未结合浓度--简短交流。
IF 3.7 3区 医学 Q1 ANESTHESIOLOGY Pub Date : 2024-10-01 DOI: 10.1016/j.accpm.2024.101419
Angela R Tognolini , Jason A Roberts , Saurabh Pandey , Steven C Wallis , Victoria A Eley

Background

Intravenous lidocaine is increasingly used as an analgesic adjunct during general anaesthesia. Lidocaine is highly protein-bound and changes to binding can alter drug efficacy or toxicity. We aimed to measure the effect of various propofol and lidocaine plasma concentration combinations on the protein binding and concentration of lidocaine in vitro.

Methods

Known targeted concentrations of propofol and lidocaine were added to drug-free human plasma in vitro. Samples were prepared and analysed in various clinically relevant concentration combinations; propofol at 0, 2, 4 and 6 µg/mL, and lidocaine at 1, 3 and 5 µg/mL. The total and unbound concentrations of lidocaine were measured by ultra-high performance liquid chromatography-mass spectrometry and percentage protein binding was determined. Data were presented as mean and standard deviation (SD) and differences between groups analysed.

Results

The overall mean protein binding of lidocaine was 68.8% (SD 5.5, range 57.5–80.9%). Beta regression analysis revealed no statistically significant difference in lidocaine percentage binding across a range of propofol and lidocaine concentration combinations.

Conclusion

Propofol did not alter the unbound and free pharmacologically active proportion of lidocaine at different clinically targeted concentrations of propofol and lidocaine in plasma in vitro. The percentage of plasma protein binding of lidocaine in this study was consistent with previously published results.
背景:静脉注射利多卡因越来越多地被用作全身麻醉期间的镇痛辅助药物。利多卡因与蛋白质的结合率很高,结合率的变化会改变药物的疗效或毒性。我们的目的是在体外测量各种丙泊酚和利多卡因血浆浓度组合对利多卡因蛋白结合和浓度的影响:方法:在体外将已知目标浓度的丙泊酚和利多卡因添加到不含药物的人体血浆中。制备并分析各种临床相关浓度组合的样本;异丙酚浓度为 0、2、4 和 6 µg/mL,利多卡因浓度为 1、3 和 5 µg/mL。采用超高效液相色谱-质谱法测量利多卡因的总浓度和未结合浓度,并测定蛋白质结合百分比。数据以平均值和标准差(SD)以及分析组之间的差异表示:结果:利多卡因的总平均蛋白结合率为 68.8%(标准差为 5.5,范围为 57.5-80.9%)。贝塔回归分析表明,在一系列丙泊酚和利多卡因浓度组合中,利多卡因的结合率没有显著的统计学差异:结论:丙泊酚不会改变血浆中不同临床目标浓度丙泊酚和利多卡因在体外的未结合和游离药理活性比例。本研究中利多卡因的血浆蛋白结合率与之前发表的结果一致。
{"title":"Propofol does not alter the protein binding and unbound concentration of lidocaine at clinically targeted plasma concentrations in vitro – A short communication","authors":"Angela R Tognolini ,&nbsp;Jason A Roberts ,&nbsp;Saurabh Pandey ,&nbsp;Steven C Wallis ,&nbsp;Victoria A Eley","doi":"10.1016/j.accpm.2024.101419","DOIUrl":"10.1016/j.accpm.2024.101419","url":null,"abstract":"<div><h3>Background</h3><div>Intravenous lidocaine is increasingly used as an analgesic adjunct during general anaesthesia. Lidocaine is highly protein-bound and changes to binding can alter drug efficacy or toxicity. We aimed to measure the effect of various propofol and lidocaine plasma concentration combinations on the protein binding and concentration of lidocaine <em>in vitro</em>.</div></div><div><h3>Methods</h3><div>Known targeted concentrations of propofol and lidocaine were added to drug-free human plasma <em>in vitro</em>. Samples were prepared and analysed in various clinically relevant concentration combinations; propofol at 0, 2, 4 and 6 µg/mL, and lidocaine at 1, 3 and 5 µg/mL. The total and unbound concentrations of lidocaine were measured by ultra-high performance liquid chromatography-mass spectrometry and percentage protein binding was determined. Data were presented as mean and standard deviation (SD) and differences between groups analysed.</div></div><div><h3>Results</h3><div>The overall mean protein binding of lidocaine was 68.8% (SD 5.5, range 57.5–80.9%). Beta regression analysis revealed no statistically significant difference in lidocaine percentage binding across a range of propofol and lidocaine concentration combinations.</div></div><div><h3>Conclusion</h3><div>Propofol did not alter the unbound and free pharmacologically active proportion of lidocaine at different clinically targeted concentrations of propofol and lidocaine in plasma <em>in vitro</em>. The percentage of plasma protein binding of lidocaine in this study was consistent with previously published results.</div></div>","PeriodicalId":48762,"journal":{"name":"Anaesthesia Critical Care & Pain Medicine","volume":"43 5","pages":"Article 101419"},"PeriodicalIF":3.7,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141876429","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The efficacy of magnesium sulphate in preventing laryngospasm in paediatric patients undergoing general anaesthesia: A systematic review and meta-analysis of randomised control trials 硫酸镁对接受全身麻醉的儿科患者预防喉痉挛的疗效:随机对照试验的系统回顾和荟萃分析。
IF 3.7 3区 医学 Q1 ANESTHESIOLOGY Pub Date : 2024-10-01 DOI: 10.1016/j.accpm.2024.101413
Mohammad Ahmed Rasheed , Danyal Memon , Clare Keaveney Jimenez , Asad Zafar , Haaris Shiwani

Background

Laryngospasm is sustained closure of the airways and can be a life-threatening condition. Magnesium sulphate is postulated to reduce the incidence of laryngospasm if administered peri-operatively. This systematic review and meta-analysis was performed to assess the efficacy of magnesium sulphate in preventing peri-operative laryngospasm in paediatric patients undergoing non-cardiac surgery.

Methods

Four databases and a trial registry were searched. Inclusion criteria were paediatric patients undergoing general anaesthesia. Exclusion criteria were patients who underwent cardiopulmonary bypass during surgery. The intervention of interest was the peri-operative administration of magnesium sulphate. The intervention was compared to either a placebo or other pharmacological agent.
The primary outcome was the incidence of laryngospasm. A meta-analysis of all studies was performed. Sub-group analysis was subsequently performed.

Results

A total of 953 patients from 13 trials were included in this study. Nine RCTs administered magnesium intravenously and 4 RCTs administered magnesium locally. Laryngospasm rates were 6% lower in the magnesium group (OR 0.48 [95% CI 0.25–0.96], p = 0.04) compared to control in the pooled data. Subgroup analysis showed laryngospasm rates were lower by 12.5% (Odds Ratio 0.26 [CI 0.09–0.76], p = 0.01) in the local magnesium group. Subgroup analysis of studies that only administered intravenous magnesium did not show a statistically significant difference in the incidence of laryngospasm (OR 0.73 [95% CI 0.33–1.63], p = 0.44).

Conclusions

This review shows a potential role for magnesium in the prevention of laryngospasm in paediatric patients undergoing general anaesthesia. There is a correlation between local administration of magnesium and reduction in laryngospasm rates. Further studies are required to assess the efficacy of intravenous magnesium in prevention of laryngospasm.

Registration

Prospective Register of Systematic Reviews (PROSPERO); PROSPERO ID CRD42022307868 (https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42022307868).
背景:喉痉挛是指呼吸道持续关闭,可危及生命。据推测,如果在围手术期使用硫酸镁,可降低喉痉挛的发生率。本系统综述和荟萃分析旨在评估硫酸镁对接受非心脏手术的儿科患者围手术期喉痉挛的预防效果:方法:检索了四个数据库和一个试验登记处。纳入标准为接受全身麻醉的儿科患者。排除标准是在手术过程中接受心肺旁路治疗的患者。所关注的干预措施是围手术期服用硫酸镁。该干预措施与安慰剂或其他药剂进行了比较。主要结果是喉痉挛的发生率。对所有研究进行了荟萃分析。随后进行了分组分析:本研究共纳入了 13 项试验中的 953 名患者。9项研究采用静脉注射镁剂,4项研究采用局部注射镁剂。在汇总数据中,镁剂组的喉痉挛发生率比对照组低 6%(OR 0.48 [95% CI 0.25-0.96],P = 0.04)。亚组分析显示,局部镁组的喉痉挛发生率降低了 12.5%(Odds Ratio 0.26 [CI 0.09-0.76],p = 0.01)。对仅静脉注射镁的研究进行的分组分析表明,喉痉挛发生率的差异无统计学意义(OR 0.73 [95% CI 0.33-1.63],P = 0.44):本综述显示了镁在预防接受全身麻醉的儿科患者喉痉挛方面的潜在作用。局部给药镁与降低喉痉挛发生率之间存在相关性。需要进一步的研究来评估静脉注射镁对预防喉痉挛的疗效:系统综述前瞻性注册(PROSPERO);PROSPERO ID CRD42022307868 (https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42022307868)。
{"title":"The efficacy of magnesium sulphate in preventing laryngospasm in paediatric patients undergoing general anaesthesia: A systematic review and meta-analysis of randomised control trials","authors":"Mohammad Ahmed Rasheed ,&nbsp;Danyal Memon ,&nbsp;Clare Keaveney Jimenez ,&nbsp;Asad Zafar ,&nbsp;Haaris Shiwani","doi":"10.1016/j.accpm.2024.101413","DOIUrl":"10.1016/j.accpm.2024.101413","url":null,"abstract":"<div><h3>Background</h3><div>Laryngospasm is sustained closure of the airways and can be a life-threatening condition. Magnesium sulphate is postulated to reduce the incidence of laryngospasm if administered peri-operatively. This systematic review and meta-analysis was performed to assess the efficacy of magnesium sulphate in preventing peri-operative laryngospasm in paediatric patients undergoing non-cardiac surgery.</div></div><div><h3>Methods</h3><div>Four databases and a trial registry were searched. Inclusion criteria were paediatric patients undergoing general anaesthesia. Exclusion criteria were patients who underwent cardiopulmonary bypass during surgery. The intervention of interest was the peri-operative administration of magnesium sulphate. The intervention was compared to either a placebo or other pharmacological agent.</div><div>The primary outcome was the incidence of laryngospasm. A meta-analysis of all studies was performed. Sub-group analysis was subsequently performed.</div></div><div><h3>Results</h3><div>A total of 953 patients from 13 trials were included in this study. Nine RCTs administered magnesium intravenously and 4 RCTs administered magnesium locally. Laryngospasm rates were 6% lower in the magnesium group (OR 0.48 [95% CI 0.25–0.96], <em>p</em> = 0.04) compared to control in the pooled data. Subgroup analysis showed laryngospasm rates were lower by 12.5% (Odds Ratio 0.26 [CI 0.09–0.76], <em>p</em> = 0.01) in the local magnesium group. Subgroup analysis of studies that only administered intravenous magnesium did not show a statistically significant difference in the incidence of laryngospasm (OR 0.73 [95% CI 0.33–1.63], <em>p</em> = 0.44).</div></div><div><h3>Conclusions</h3><div>This review shows a potential role for magnesium in the prevention of laryngospasm in paediatric patients undergoing general anaesthesia. There is a correlation between local administration of magnesium and reduction in laryngospasm rates. Further studies are required to assess the efficacy of intravenous magnesium in prevention of laryngospasm.</div></div><div><h3>Registration</h3><div>Prospective Register of Systematic Reviews (PROSPERO); PROSPERO ID CRD42022307868 (<span><span>https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42022307868</span><svg><path></path></svg></span>).</div></div>","PeriodicalId":48762,"journal":{"name":"Anaesthesia Critical Care & Pain Medicine","volume":"43 5","pages":"Article 101413"},"PeriodicalIF":3.7,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141876431","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preoperative anaesthesia and other team meetings for complex cases: a narrative review 复杂病例的术前麻醉和其他团队会议:叙述性回顾。
IF 3.7 3区 医学 Q1 ANESTHESIOLOGY Pub Date : 2024-10-01 DOI: 10.1016/j.accpm.2024.101421
Antoine Baumann , Dan Benhamou

Background

The conventional two-step process for surgical procedures – surgical followed by anaesthetic consultation - may not adequately address the needs of complex cases involving high-risk patients or procedures, leading to increased risks of adverse events. Although surgical team meetings (STM) and multidisciplinary team meetings (MDTM) were implemented many years ago, anaesthesia team meetings (ATM) have recently emerged as potential solutions to enhance perioperative management.

Purpose

We aim to systematically review and summarize the existing literature that reflects the main theoretical approaches, practices, effects, and clinical relevance of preoperative team meetings - with specific consideration to preoperative ATM - in managing difficult cases.

Methods

We performed a narrative review of the literature (1980–2024) to identify studies focusing on the practice and the impact of preoperative meetings on patient outcomes, compliance with treatment plans, and teamwork quality. We provide here a qualitative synthesis of the findings.

Results

Fourteen studies were identified: 11 consider preoperative multidisciplinary team meeting (MDTM), 2 consider preoperative surgical team meeting (STM), and only one anaesthesia team meeting (ATM).

Conclusions

There is currently not enough robust evidence that preoperative team meetings clearly improve hard patient’s outcome parameters. And the place for ATM does not appear to have been studied to date. There is a need for well-designed studies to explore the impact of preoperative ATM on clinical practice improvement, quality of care, and patient outcomes.
背景:外科手术的传统两步流程--先手术后麻醉会诊--可能无法充分满足涉及高风险患者或手术的复杂病例的需求,从而导致不良事件的风险增加。尽管手术团队会议(STM)和多学科团队会议(MDTM)在多年前就已实施,但麻醉团队会议(ATM)近来已成为加强围手术期管理的潜在解决方案。目的:我们旨在系统回顾和总结现有文献,这些文献反映了术前团队会议(特别是术前ATM)在管理疑难病例方面的主要理论方法、实践、效果和临床意义:我们对文献(1980 - 2024 年)进行了叙事性回顾,以确定有关术前会议的实践及其对患者预后、治疗计划依从性和团队合作质量的影响的研究。我们在此对研究结果进行了定性综述:结果:共发现 14 项研究:11 项研究考虑了术前多学科团队会议 (MDTM),2 项研究考虑了术前手术团队会议 (STM),只有一项研究考虑了麻醉团队会议 (ATM):结论:目前还没有足够有力的证据表明术前团队会议能明显改善患者的预后参数。迄今为止,似乎尚未对 ATM 的地位进行过研究。有必要进行精心设计的研究,探讨术前团队会议对临床实践改进、护理质量和患者预后的影响。
{"title":"Preoperative anaesthesia and other team meetings for complex cases: a narrative review","authors":"Antoine Baumann ,&nbsp;Dan Benhamou","doi":"10.1016/j.accpm.2024.101421","DOIUrl":"10.1016/j.accpm.2024.101421","url":null,"abstract":"<div><h3>Background</h3><div>The conventional two-step process for surgical procedures – surgical followed by anaesthetic consultation - may not adequately address the needs of complex cases involving high-risk patients or procedures, leading to increased risks of adverse events. Although surgical team meetings (STM) and multidisciplinary team meetings (MDTM) were implemented many years ago, anaesthesia team meetings (ATM) have recently emerged as potential solutions to enhance perioperative management.</div></div><div><h3>Purpose</h3><div>We aim to systematically review and summarize the existing literature that reflects the main theoretical approaches, practices, effects, and clinical relevance of preoperative team meetings - with specific consideration to preoperative ATM - in managing difficult cases.</div></div><div><h3>Methods</h3><div>We performed a narrative review of the literature (1980–2024) to identify studies focusing on the practice and the impact of preoperative meetings on patient outcomes, compliance with treatment plans, and teamwork quality. We provide here a qualitative synthesis of the findings.</div></div><div><h3>Results</h3><div>Fourteen studies were identified: 11 consider preoperative multidisciplinary team meeting (MDTM), 2 consider preoperative surgical team meeting (STM), and only one anaesthesia team meeting (ATM).</div></div><div><h3>Conclusions</h3><div>There is currently not enough robust evidence that preoperative team meetings clearly improve hard patient’s outcome parameters. And the place for ATM does not appear to have been studied to date. There is a need for well-designed studies to explore the impact of preoperative ATM on clinical practice improvement, quality of care, and patient outcomes.</div></div>","PeriodicalId":48762,"journal":{"name":"Anaesthesia Critical Care & Pain Medicine","volume":"43 5","pages":"Article 101421"},"PeriodicalIF":3.7,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141890599","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How green is my reusable bronchoscope? 我的可重复使用支气管镜有多环保?
IF 3.7 3区 医学 Q1 ANESTHESIOLOGY Pub Date : 2024-10-01 DOI: 10.1016/j.accpm.2024.101420
Nicolas Massart , Christophe Millet , Hélène Beloeil , Pierre Fillatre , Caroline Rouxel , Magalie Daudin , Nicolas Coullier , Véronique Marie , Elodie Peguet , Pierre Bardoult

Introduction

Single-use bronchoscopes have replaced reusable ones in many institutions. This study aimed to evaluate the environmental and financial impacts of both strategies: reusable and single-use bronchoscopes.

Material and methods

We conducted a pragmatic study in a 21-bed polyvalent ICU, in Saint-Brieuc, Bretagne, France. The eco-audit consisted of estimating greenhouse gas (GHG) emissions, considering the life cycle of each strategy. Greenhouse gas (GHG) emissions related to construction, packaging, transport and waste elimination were compared between 2 devices: the reusable bronchoscope, a Pentax® FI-16RBS that was disinfected twice daily; and the single-use bronchoscope, the bronchoflex agile® from TSC.

Results

For the reusable bronchoscope, GHG emissions were marginally impacted by the number of bronchoscopies performed (from 185 kg eq.CO2 per year to 192 kg eq.CO2 for 10 or 110 bronchoscopies per year). For the reusable device, GHG emissions directly depended on the number of bronchoscopies performed with 3.82 kg eq.CO2 emitted per bronchoscopy. The breakeven point for the reusable bronchoscope was estimated at 50 bronchoscopies in terms of GHG emissions and 96 bronchoscopies for financial considerations.

Conclusion

Considering current practice in our ICU, reusable bronchoscopes have lower GHG emissions when used more than 50 times a year and a lower cost when used more than 96 times a year as compared with single-use bronchoscopes.
导读在许多机构,一次性支气管镜已经取代了可重复使用的支气管镜。本研究旨在评估可重复使用和一次性支气管镜这两种策略对环境和经济的影响:我们在法国布列塔尼省圣布里厄市(Saint-Brieuc)一家拥有 21 张病床的多学科重症监护病房进行了一项实用性研究。生态审计包括估算温室气体(GHG)排放量,同时考虑到每种策略的生命周期。比较了两种设备在制造、包装、运输和废物处理方面的温室气体排放量:可重复使用的支气管镜(每天消毒两次的 Pentax® FI-16RBS)和一次性支气管镜(TSC 的 bronchoflex agile®):结果:对于可重复使用的支气管镜,支气管镜手术次数对温室气体排放量的影响很小(从每年 185 千克二氧化碳当量到每年 10 或 110 次支气管镜手术的 192 千克二氧化碳当量)。对于可重复使用的设备,温室气体排放量直接取决于支气管镜检查的次数,每次支气管镜检查排放 3.82 千克二氧化碳当量。可重复使用支气管镜的盈亏平衡点估计为 50 次支气管镜检查的温室气体排放量和 96 次支气管镜检查的经济效益:结论:考虑到我们重症监护室目前的做法,与一次性支气管镜相比,可重复使用支气管镜每年使用超过 50 次时,温室气体排放量较低;每年使用超过 96 次时,成本较低。
{"title":"How green is my reusable bronchoscope?","authors":"Nicolas Massart ,&nbsp;Christophe Millet ,&nbsp;Hélène Beloeil ,&nbsp;Pierre Fillatre ,&nbsp;Caroline Rouxel ,&nbsp;Magalie Daudin ,&nbsp;Nicolas Coullier ,&nbsp;Véronique Marie ,&nbsp;Elodie Peguet ,&nbsp;Pierre Bardoult","doi":"10.1016/j.accpm.2024.101420","DOIUrl":"10.1016/j.accpm.2024.101420","url":null,"abstract":"<div><h3>Introduction</h3><div>Single-use bronchoscopes have replaced reusable ones in many institutions. This study aimed to evaluate the environmental and financial impacts of both strategies: reusable and single-use bronchoscopes.</div></div><div><h3>Material and methods</h3><div>We conducted a pragmatic study in a 21-bed polyvalent ICU, in Saint-Brieuc, Bretagne, France. The eco-audit consisted of estimating greenhouse gas (GHG) emissions, considering the life cycle of each strategy. Greenhouse gas (GHG) emissions related to construction, packaging, transport and waste elimination were compared between 2 devices: the reusable bronchoscope, a Pentax® FI-16RBS that was disinfected twice daily; and the single-use bronchoscope, the bronchoflex agile® from TSC.</div></div><div><h3>Results</h3><div>For the reusable bronchoscope, GHG emissions were marginally impacted by the number of bronchoscopies performed (from 185 kg eq.CO<sub>2</sub> per year to 192 kg eq.CO<sub>2</sub> for 10 or 110 bronchoscopies per year). For the reusable device, GHG emissions directly depended on the number of bronchoscopies performed with 3.82 kg eq.CO<sub>2</sub> emitted per bronchoscopy. The breakeven point for the reusable bronchoscope was estimated at 50 bronchoscopies in terms of GHG emissions and 96 bronchoscopies for financial considerations.</div></div><div><h3>Conclusion</h3><div>Considering current practice in our ICU, reusable bronchoscopes have lower GHG emissions when used more than 50 times a year and a lower cost when used more than 96 times a year as compared with single-use bronchoscopes.</div></div>","PeriodicalId":48762,"journal":{"name":"Anaesthesia Critical Care & Pain Medicine","volume":"43 5","pages":"Article 101420"},"PeriodicalIF":3.7,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141876425","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of two different positions of an anaesthesiologist for ease of endotracheal intubation in adult patients: A randomised control trial 比较麻醉师的两种不同体位对成年患者气管插管的易用性:随机对照试验。
IF 3.7 3区 医学 Q1 ANESTHESIOLOGY Pub Date : 2024-10-01 DOI: 10.1016/j.accpm.2024.101422
Poonam Kumari, Amarjeet Kumar, Chandni Sinha, Ajeet Kumar, Kunal Singh

Background and aims

Maintaining the airway with a cuffed endotracheal tube (ETT) in the trachea remains one of the most essential anaesthesia skills. Many parameters were described to assess the difficulty of intubation in the preoperative period, but none allow the prediction of all difficult intubations. The correct posture of the anaesthesiologist is also an important factor for successful endotracheal intubation. The aim of this study was. This study aimed to compare the impact of two different positions of an anaesthesiologist (sitting vs. standing) at the time of endotracheal intubation.

Methods

One hundred ten American Society of Anaesthesiologists (ASA) Physical Status I/II patients, aged between 17 to 65 years, Mallampati grade I/II, mouth opening 39–70 mm, thyromental distance (TMD) 6–6.5 cm, and sternomental distance (SMD) >13 cm, scheduled for elective laparoscopic cholecystectomy, were recruited. Patients were divided into two groups; Group I consisted of patients who underwent endotracheal intubation by an anaesthesiologist in a sitting posture, while Group II encompassed patients who underwent endotracheal intubation by anaesthesiologists in a standing posture. Assessment parameters include ease of intubation (IDS score), intubation time, intubation success rate, number of attempts, grade of laryngoscopy (Cormack Lehane score, POGO score), and complications like tooth and soft tissue damage.

Results

The ease of intubation was higher in group I, 1(0–1), than in group II, 1(1−2) (p =  0.02), and there was a significant difference between the two groups. The Cormack Lehane grade (CL) was I/IIa/IIb/III in 19/23/13/0 in group I and I/IIa/IIb/III in 13/21/18/3 in group II. The first-attempt intubation success rate for groups I and II was 94.54 % and 92.72 % respectively.

Conclusion

The sitting posture of an anaesthesiologist at the time of laryngoscopy provides a better intubating condition when compared with the standing posture.

Registration

Clinical Trial Registry - India (CTRI) CTRI/2023/03/050371.
背景和目的:在气管内使用带袖带的气管导管(ETT)保持气道通畅仍然是最基本的麻醉技能之一。许多参数被用来评估术前插管的难度,但没有一个参数可以预测所有困难插管。麻醉师的正确姿势也是成功进行气管插管的重要因素。本研究的目的是本研究旨在比较麻醉医师在气管插管时两种不同姿势(坐姿与站姿)的影响:方法:招募了 110 名美国麻醉医师协会(ASA)身体状况 I/II 级患者,年龄在 17 至 65 岁之间,Mallampati I/II 级,张口 39 至 70 毫米,甲状腺距离(TMD)6 至 6.5 厘米,胸骨距离(SMD)大于 13 厘米,计划进行择期腹腔镜胆囊切除术。患者被分为两组,第一组包括由麻醉师以坐姿进行气管插管的患者,第二组包括由麻醉师以站立姿势进行气管插管的患者。评估参数包括插管难易程度(IDS 评分)、插管时间、插管成功率、尝试次数、喉镜检查等级(Cormack Lehane 评分、POGO 评分)以及牙齿和软组织损伤等并发症:结果:第一组(1(0-1))的插管难易度高于第二组(1(1-2))(P = 0.02),两组之间存在显著差异。I 组中 19/23/13/0 的 Cormack Lehane 分级(CL)为 I/IIa/IIb/III,II 组中 13/21/18/3 的 Cormack Lehane 分级(CL)为 I/IIa/IIb/III。第一组和第二组的首次尝试插管成功率分别为 94.54 % 和 92.72 %:结论:与站立姿势相比,麻醉医生在喉镜检查时的坐姿能提供更好的插管条件:注册:印度临床试验注册中心(CTRI)CTRI/2023/03/050371。
{"title":"Comparison of two different positions of an anaesthesiologist for ease of endotracheal intubation in adult patients: A randomised control trial","authors":"Poonam Kumari,&nbsp;Amarjeet Kumar,&nbsp;Chandni Sinha,&nbsp;Ajeet Kumar,&nbsp;Kunal Singh","doi":"10.1016/j.accpm.2024.101422","DOIUrl":"10.1016/j.accpm.2024.101422","url":null,"abstract":"<div><h3>Background and aims</h3><div>Maintaining the airway with a cuffed endotracheal tube (ETT) in the trachea remains one of the most essential anaesthesia skills. Many parameters were described to assess the difficulty of intubation in the preoperative period, but none allow the prediction of all difficult intubations. The correct posture of the anaesthesiologist is also an important factor for successful endotracheal intubation. The aim of this study was. This study aimed to compare the impact of two different positions of an anaesthesiologist (sitting <em>vs</em>. standing) at the time of endotracheal intubation.</div></div><div><h3>Methods</h3><div>One hundred ten American Society of Anaesthesiologists (ASA) Physical Status I/II patients, aged between 17 to 65 years, Mallampati grade I/II, mouth opening 39–70 mm, thyromental distance (TMD) 6–6.5 cm, and sternomental distance (SMD) &gt;13 cm, scheduled for elective laparoscopic cholecystectomy, were recruited. Patients were divided into two groups; Group I consisted of patients who underwent endotracheal intubation by an anaesthesiologist in a sitting posture, while Group II encompassed patients who underwent endotracheal intubation by anaesthesiologists in a standing posture. Assessment parameters include ease of intubation (IDS score), intubation time, intubation success rate, number of attempts, grade of laryngoscopy (Cormack Lehane score, POGO score), and complications like tooth and soft tissue damage.</div></div><div><h3>Results</h3><div>The ease of intubation was higher in group I, 1(0–1), than in group II, 1(1−2) (<em>p</em> =  0.02), and there was a significant difference between the two groups. The Cormack Lehane grade (CL) was I/IIa/IIb/III in 19/23/13/0 in group I and I/IIa/IIb/III in 13/21/18/3 in group II. The first-attempt intubation success rate for groups I and II was 94.54 % and 92.72 % respectively.</div></div><div><h3>Conclusion</h3><div>The sitting posture of an anaesthesiologist at the time of laryngoscopy provides a better intubating condition when compared with the standing posture.</div></div><div><h3>Registration</h3><div>Clinical Trial Registry - India (CTRI) CTRI/2023/03/050371.</div></div>","PeriodicalId":48762,"journal":{"name":"Anaesthesia Critical Care & Pain Medicine","volume":"43 5","pages":"Article 101422"},"PeriodicalIF":3.7,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141879690","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Methodological challenges in rapid molecular testing for pneumonia: Insights and future directions for performing “the perfect” study 肺炎快速分子检测的方法挑战:开展 "完美 "研究的启示和未来方向。
IF 3.7 3区 医学 Q1 ANESTHESIOLOGY Pub Date : 2024-10-01 DOI: 10.1016/j.accpm.2024.101415
Antoni Torres , Laia Fernández-Barat
{"title":"Methodological challenges in rapid molecular testing for pneumonia: Insights and future directions for performing “the perfect” study","authors":"Antoni Torres ,&nbsp;Laia Fernández-Barat","doi":"10.1016/j.accpm.2024.101415","DOIUrl":"10.1016/j.accpm.2024.101415","url":null,"abstract":"","PeriodicalId":48762,"journal":{"name":"Anaesthesia Critical Care & Pain Medicine","volume":"43 5","pages":"Article 101415"},"PeriodicalIF":3.7,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141876427","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Combined hypoglossal and lingual nerve palsy: An unrecognized complication after orotracheal intubation for general anaesthesia. A case report of a day surgery patient and a literature review 舌下神经和舌神经联合麻痹:全身麻醉气管插管后一种未被发现的并发症。日间手术患者的病例报告和文献综述。
IF 3.7 3区 医学 Q1 ANESTHESIOLOGY Pub Date : 2024-10-01 DOI: 10.1016/j.accpm.2024.101418
Laure Cazenave , Philippe Mahiou , John Swan , Philippe Clavert , Johannes Barth
Cranial nerve injury after orotracheal intubation is a rare complication, which has varied etiology. We present a case of combined unilateral hypoglossal and lingual nerve palsy after orotracheal intubation. The current literature was reviewed for the diagnostic, treatment, follow-up, and preventive measures of this complication.
气管插管后颅神经损伤是一种罕见的并发症,其病因多种多样。我们报告了一例气管插管后合并单侧舌下神经和舌神经麻痹的病例。我们查阅了现有文献,以了解该并发症的诊断、治疗、随访和预防措施。
{"title":"Combined hypoglossal and lingual nerve palsy: An unrecognized complication after orotracheal intubation for general anaesthesia. A case report of a day surgery patient and a literature review","authors":"Laure Cazenave ,&nbsp;Philippe Mahiou ,&nbsp;John Swan ,&nbsp;Philippe Clavert ,&nbsp;Johannes Barth","doi":"10.1016/j.accpm.2024.101418","DOIUrl":"10.1016/j.accpm.2024.101418","url":null,"abstract":"<div><div>Cranial nerve injury after orotracheal intubation is a rare complication, which has varied etiology. We present a case of combined unilateral hypoglossal and lingual nerve palsy after orotracheal intubation. The current literature was reviewed for the diagnostic, treatment, follow-up, and preventive measures of this complication.</div></div>","PeriodicalId":48762,"journal":{"name":"Anaesthesia Critical Care & Pain Medicine","volume":"43 5","pages":"Article 101418"},"PeriodicalIF":3.7,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141879689","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Universal use of videolaryngoscope for all intubations in the ICU: The time is now! 在重症监护室的所有插管过程中普遍使用视频喉镜:时不我待!
IF 3.7 3区 医学 Q1 ANESTHESIOLOGY Pub Date : 2024-10-01 DOI: 10.1016/j.accpm.2024.101417
Clément Monet , Philippe Richebé , Samir Jaber
{"title":"Universal use of videolaryngoscope for all intubations in the ICU: The time is now!","authors":"Clément Monet ,&nbsp;Philippe Richebé ,&nbsp;Samir Jaber","doi":"10.1016/j.accpm.2024.101417","DOIUrl":"10.1016/j.accpm.2024.101417","url":null,"abstract":"","PeriodicalId":48762,"journal":{"name":"Anaesthesia Critical Care & Pain Medicine","volume":"43 5","pages":"Article 101417"},"PeriodicalIF":3.7,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141876432","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Anaesthesia Critical Care & Pain Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1